[Osteoporosis: prevention of bone loss and fractures].
Pfeifer
Michael
M
Institut für Klinische Osteologie Gustav Pommer und Klinik Der Fürstenhof, Bad Pyrmont. iko_pyrmont@t-online.de
Begerow
Bettina
B
Pollähne
Wolfgang
W
Minne
Helmut W
HW
D015502:Absorptiometry, Photon; D000368:Aged; D000369:Aged, 80 and over; D019386:Alendronate / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000188:drug therapy / Q000517:prevention & control; D003937:Diagnosis, Differential; D015444:Exercise; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control*; D006620:Hip Fractures / Q000000981:diagnostic imaging / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D015663:Osteoporosis, Postmenopausal; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D012307:Risk Factors; D016103:Spinal Fractures / Q000000981:diagnostic imaging / Q000517:prevention & control; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D020849:Raloxifene Hydrochloride; D019386:Alendronate